pd 135158 has been researched along with medetomidine in 1 studies
Studies (pd 135158) | Trials (pd 135158) | Recent Studies (post-2010) (pd 135158) | Studies (medetomidine) | Trials (medetomidine) | Recent Studies (post-2010) (medetomidine) |
---|---|---|---|---|---|
51 | 0 | 0 | 1,335 | 296 | 444 |
Protein | Taxonomy | pd 135158 (IC50) | medetomidine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickenson, AH; Hewett, K; Sullivan, AF | 1 |
1 other study(ies) available for pd 135158 and medetomidine
Article | Year |
---|---|
Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Anxiety Agents; Benzodiazepinones; Cholecystokinin; Electrophysiology; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Imidazoles; Indoles; Injections, Spinal; Male; Medetomidine; Meglumine; Morphine; Nerve Fibers; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Cholecystokinin; Receptors, Opioid; Spinal Cord | 1994 |